1992
DOI: 10.1016/0049-3848(92)90552-l
|View full text |Cite
|
Sign up to set email alerts
|

Increase in plasma thrombomodulin in systemic lupus erythematosus with antiphospholipid antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
10
0

Year Published

1994
1994
2002
2002

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 0 publications
2
10
0
Order By: Relevance
“…Increased sTM levels have recently been demonstrated in patients with thrombotic thrombocytopenic purpura and in a selected group of SLE patients with antiphospholipid antibody syndrome (13)(14)(15). In our investigations of unselected SLE patients in all stages of disease, we found a very close correlation between sTM levels and clinical activity of disease.…”
Section: Discussionsupporting
confidence: 63%
“…Increased sTM levels have recently been demonstrated in patients with thrombotic thrombocytopenic purpura and in a selected group of SLE patients with antiphospholipid antibody syndrome (13)(14)(15). In our investigations of unselected SLE patients in all stages of disease, we found a very close correlation between sTM levels and clinical activity of disease.…”
Section: Discussionsupporting
confidence: 63%
“…In SLE, TM appeared to be associated with vasculitis, nephritis and central nervous system (CNS) lupus [8]. However, there was controversial data from previous small studies whether TM was associated with antiphospholipid antibodies and laboratory markers of in¯ammatory activity such as complement consumption, anti-dsDNA antibodies or lymphocytopenia [8,9,21,22].…”
Section: Discussionmentioning
confidence: 99%
“…,thrombomodulin Ag has been shown to be a marker of endothelial damage in vitro [22] and previous clinical studies have shown that plasma levels of ,thrombomodulin Ag are increased in various diseases associated with endothelial cell damage or proteolytic activity on the endothelial cell surface (DIC [23,24], adult respiratory distress syndrome (ARDS) [24], thromboembolic disease [23,24], thrombotic thrombocytopenic purpura [25,26], diabetes mellitus with microangiopathy [23,27], systemic lupus erythematosus (SLE) [28], and chronic myelogenous leukemia [29]). …”
Section: Discussionmentioning
confidence: 99%